A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling
by
Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R.
Department of Psychiatry,
University of Minnesota, Minneapolis, USA.
kimxx003@umn.edu
J Clin Psychiatry 2002 Jun;63(6):501-7


ABSTRACT

BACKGROUND: This randomized, double-blind, placebo-controlled study investigated the efficacy and tolerability of paroxetine in the treatment of pathological gambling. METHOD: Patients fulfilling DSM-IV criteria for pathological gambling and scoring > or = 5 on the South Oaks Gambling Screen were enrolled if no other Axis I disorder was present. A 1-week placebo run-in phase was followed by 8 weeks' treatment with paroxetine or placebo. The initial paroxetine dose of 20 mg/day could be increased after week 2 by 10 mg/week to a maximum of 60 mg/day. Changes in clinical status were assessed using the Gambling Symptom Assessment Scale (G-SAS) and the Clinical Global Impressions scale (CGI). Treatment-emergent symptoms were assessed weekly. RESULTS: Forty-five patients were included in an intent-to-treat analysis (N = 23 paroxetine, N = 22 placebo). Statistically significantly greater reductions in the total score of the G-SAS were observed in the paroxetine group compared with the placebo group at weeks 6 through 8 (p = .003, .003, and .042, respectively). Improvement on the CGI was also significantly greater in the paroxetine than in the placebo group at the same timepoints (p = .033, .014, and .025, respectively). A significantly greater proportion of patients in the paroxetine group were responders at weeks 7 and 8 (p = .011 and .010, respectively). CONCLUSION: The results of this trial indicate that paroxetine may be effective in the treatment of pathological gambling. There were no unexpected side effects from this treatment. However, additional studies with larger patient samples and a longer treatment phase are required to establish conclusively the efficacy and safety of paroxetine for this indication.
SSRIs
Anxiety
Serotonin
Paroxetine
Social phobia
Panic disorder
Paroxetine update
Paroxetine and suicide
Paroxetine v bupropion
Paroxetine v fluoxetine
Paroxetine v maprotiline
SSRIs and panic disorder
Antidepressant metabolism
Paroxetine and noradrenaline
OCD: mice, marbles and paroxetine
Paroxetine (Paxil, Seroxat) : structure
Tianeptine (Stablon) v paroxetine (Paxil)
Paroxetine: systematic re-examination of published and unpublished data

Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family